Admelog Injection, Solution
Product Images NDC 70518-4275

Product Visual Gallery

This gallery contains 35 technical images submitted to the FDA as part of the official labeling for Admelog (NDC 70518-4275). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Admelog SoloStar injection, a prefilled pen containing insulin lispro at 100 units/mL (U-100) strength. The package includes 5 pens, each with 3 mL of solution intended for subcutaneous use. Labeler Remedy Repack Inc. is indicated, with storage instructions and warnings also visible.*

FDA Label Image

Figure 1 (Admelog 01)

A line graph depicting glucose infusion rate (GIR) in mg/min/kg over time in hours for ADMELOG insulin lispro injection. The graph shows GIR increasing sharply to a peak around 2 hours, then gradually declining to near zero by 11-12 hours, illustrating the pharmacodynamic profile of ADMELOG after subcutaneous administration.*

FDA Label Image

Figure 2 (Admelog 02)

A line graph displaying mean plasma insulin lispro concentration (mU/L) over time (minutes). The x-axis represents time up to 480 minutes, and the y-axis represents mean plasma insulin lispro concentration up to 160 mU/L. The concentration rises sharply, peaks around 60 minutes, and then gradually declines over time.*

FDA Label Image

Step 1 (Admelog 03)

An instructional line drawing showing hands opening or handling a vial, which could be part of the preparation or administration process for an injectable medication such as ADMELOG insulin lispro injection solution.*

FDA Label Image

Step 2 (Admelog 04)

An instructional illustration showing a hand peeling or removing a protective cap from the top of a vial, likely for an injectable solution. The vial is held in one hand while the other hand removes the cap, demonstrating vial preparation before use.*

FDA Label Image

Step 3 (Admelog 05)

An instructional illustration showing how to prepare an injection using a syringe. The image depicts two hands holding the syringe and a vial, with an arrow indicating the action of drawing liquid into the syringe.*

FDA Label Image

Step 3 (Admelog 06)

An instructional illustration showing hands preparing a syringe for injection. One hand holds the syringe while the other hand removes the protective cap from the needle, indicated by an arrow pointing upwards. The image likely relates to subcutaneous injection preparation for the drug ADMELOG (insulin lispro).*

FDA Label Image

Step 4 (Admelog 07)

An instructional illustration showing hands drawing insulin lispro injection solution from a vial using a syringe. The image depicts the process of filling the syringe, emphasizing proper grip and technique for subcutaneous injection preparation.*

FDA Label Image

Step 5 (Admelog 08)

An instructional illustration showing a hand holding a syringe with a needle being positioned near the skin of a finger, indicating preparation or injection for subcutaneous administration.*

FDA Label Image

Step 7 (Admelog 09)

An illustration showing recommended subcutaneous injection sites on the human body. The diagram highlights the upper arms, stomach, thighs, and buttocks as suitable areas for injection placement.*

FDA Label Image

Step 7 (Admelog 10)

An instructional illustration shows a person's hand applying a small adhesive bandage or tape strip to the index finger of the other hand. This likely demonstrates a step in care or handling related to injection or blood monitoring.*

FDA Label Image

Step 8 (Admelog 11)

An instructional illustration showing a hand holding an insulin syringe. The image depicts the action of pushing or pulling the plunger, indicated by an arrow, likely demonstrating how to prepare or administer a subcutaneous injection.*

FDA Label Image

Image (Admelog 12)

An instructional anatomical diagram showing recommended subcutaneous injection sites for ADMELOG insulin lispro solution. Highlighted green areas include the upper arms, stomach, thighs, and buttocks on front and back views of a human figure.*

FDA Label Image

Image (Admelog 13)

An instructional diagram of the ADMELOG SoloStar insulin pen showing labeled parts including the pen cap, cartridge holder, rubber seal, insulin scale, plunger, insulin name on the cartridge, dose window and pointer, dose selector, and injection button. The image highlights user interface components for dosage selection and injection.*

FDA Label Image

Step 1a (Admelog 14)

The image shows an Admelog SoloStar prefilled pen for subcutaneous injection containing insulin lispro at 100 U/mL strength. The pen design is mostly yellow with a burgundy label highlighting the product name, strength, and indication for single patient use. The labeler is RemedyRepack Inc.*

FDA Label Image

Step 1b (Admelog 15)

An instructional illustration showing two hands holding an insulin injection pen. The left hand holds the pen with the dose window visible, and the right hand covers the pen with a yellow protective cap. The blue arrow indicates the action of placing the cap onto the pen.*

FDA Label Image

Step 1c (Admelog 16)

ADMELOG 100 U/mL insulin lispro injection in a 3 mL prefilled SoloSTAR pen for subcutaneous use. The visible portion of the pen shows dosing markings to measure insulin units, with a label indicating it is for single patient use, manufactured by RemedyRepack Inc.*

FDA Label Image

Step 1d (Admelog 17)

Illustration showing hands preparing a syringe for injection by removing a protective cover from the needle. The image focuses on safe handling and setup of an injection device, consistent with subcutaneous administration of medications like insulin lispro.*

FDA Label Image

Step 2a (Admelog 18)

An instructional illustration showing a person removing the protective cap from a syringe or injection pen. The image depicts hands holding the device, emphasizing the cap removal step prior to subcutaneous injection.*

FDA Label Image

Step 2b (Admelog 19)

An instructional illustration showing hands removing a cap from an ADMELOG insulin lispro injection pen. The image uses arrows to indicate the correct twisting and pulling motion to remove the cap and includes a warning inset demonstrating to avoid pulling the needle off incorrectly.*

FDA Label Image

Step 2c (Admelog 20)

An instructional illustration showing a hand holding a syringe prefilled with Admelog (insulin lispro) injection, solution, 100 U/mL. A separate close-up inset depicts a hand removing the needle cap from the syringe prior to subcutaneous injection.*

FDA Label Image

Step 2d (Admelog 21)

Illustration showing the process of removing a protective cap from a vial while holding a syringe, likely demonstrating preparation for drawing a subcutaneous injection of ADMELOG insulin lispro 100 U/mL.*

FDA Label Image

Step 3a (Admelog 22)

Illustration showing a hand holding an ADMELOG SoloStar insulin pen and adjusting the dose by turning the dial on the pen. An inset close-up highlights the dose window displaying the number 2, indicating the selected units for injection.*

FDA Label Image

Step 3b (Admelog 23)

An instructional illustration showing the technique of priming a syringe filled with ADMELOG insulin lispro injection solution. The image depicts a hand holding the syringe with the needle pointing upward, and a small amount of liquid being expelled from the needle tip, demonstrating air removal before injection.*

FDA Label Image

Step 4a (Admelog 24)

ADMELOG 100 U/mL insulin lispro injection in a SoloStar prefilled disposable pen for subcutaneous use. The pen has a clear barrel displaying dosage markings and a purple and white label showing the proprietary name, strength, and single-patient use indication. The pen's cap is yellow with a 10-unit dosage indicator.*

FDA Label Image

Step 4b (Admelog 25)

An instructional illustration showing hands preparing an ADMELOG SoloStar insulin pen for injection. One hand holds the pen body, while the other is rotating the pen's purple cap upward to remove it, indicated by a blue arrow and a 180-degree rotation symbol.*

FDA Label Image

Step 4b (Admelog 26)

Illustration showing the dosage window on an insulin pen injector. The window displays dosage numbers 10 and 20, indicating the dial setting for insulin delivery, relevant to subcutaneous injection of insulin lispro.*

FDA Label Image

Step 4b (Admelog 27)

FDA Label Image

Step 5b (Admelog 28)

An instructional illustration showing a hand holding an ADMELOG 100 U/mL insulin lispro injection pen. The diagram highlights the correct finger positioning on the pen and indicates pulling the dose knob backward with a blue arrow, demonstrating how to prepare or adjust the dose before injection.*

FDA Label Image

Step 5c (Admelog 29)

An instructional illustration showing the proper method to set the dose on an insulin pen for ADMELOG (insulin lispro) injection, 100 U/mL. It demonstrates rotating the dose knob with the thumb and forefinger, emphasizing the correct clockwise motion with a blue arrow and highlighting the dial display. A close-up inset shows the dose window with correct alignment, while a red circle with a slash indicates an incorrect way to turn the knob.*

FDA Label Image

Step 5d (Admelog 30)

Illustration showing the proper technique for preparing and holding the ADMELOG insulin lispro injection pen. The image highlights pressing and holding the pen button for 10 seconds before withdrawing the needle, emphasizing correct subcutaneous injection procedure.*

FDA Label Image

Step 6a (Admelog 31)

An instructional illustration showing a hand holding an ADMELOG insulin lispro 100 U/mL prefilled pen injection device. The image depicts the removal of the needle cap from the pen, indicated by a blue arrow pointing away from the cap.*

FDA Label Image

Step 6b (Admelog 32)

An instructional diagram showing how to prepare or use a cartridge or pen injector. It depicts one hand holding the cartridge and the other hand twisting the top cap, with blue arrows indicating the twisting and pressing directions.*

FDA Label Image

Step 6c (Admelog 33)

An instructional illustration showing hands opening a container and inserting a small vial or container into it, demonstrating a step in the preparation or handling of the medication.*

FDA Label Image

Step 6d (Admelog 34)

An instructional illustration demonstrating removal of the yellow protective cap from an ADMELOG insulin lispro injection pen. The image shows hands gripping the pen and cap, with a blue arrow indicating the direction to pull the cap off the injection pen.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.